Search | VHL Search Portal

1.

It Is Time to Reconsider the 3% Discount Rate.

Cohen, Joshua T.

Value Health ; 27(5): 578-584, 2024 May.

Article in English | MEDLINE | ID: mdl-38462224

2.

The Impact on Cost-Effectiveness of Accounting for Generic Drug Pricing: Four Case Studies.

Cohen, Joshua T.

Value Health ; 26(3): 344-350, 2023 03.

Article in English | MEDLINE | ID: mdl-36336585

3.

A review of HTA guidelines on societal and novel value elements.

Breslau, Rachel Milstein; Cohen, Joshua T; Diaz, Jose; Malcolm, Bill; Neumann, Peter J.

Int J Technol Assess Health Care ; 39(1): e31, 2023 May 25.

Article in English | MEDLINE | ID: mdl-37226807

4.

Alzheimer's disease medication use and adherence patterns by race and ethnicity.

Olchanski, Natalia; Daly, Allan T; Zhu, Yingying; Breslau, Rachel; Cohen, Joshua T; Neumann, Peter J; Faul, Jessica D; Fillit, Howard M; Freund, Karen M; Lin, Pei-Jung.

Alzheimers Dement ; 19(4): 1184-1193, 2023 04.

Article in English | MEDLINE | ID: mdl-35939325

5.

Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.

Lavelle, Tara A; Feng, Xue; Keisler, Marlena; Cohen, Joshua T; Neumann, Peter J; Prichard, Daryl; Schroeder, Brock E; Salyakina, Daria; Espinal, Paula S; Weidner, Samuel B; Maron, Jill L.

Genet Med ; 24(6): 1349-1361, 2022 06.

Article in English | MEDLINE | ID: mdl-35396982

6.

Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications.

Neumann, Peter J; Podolsky, Meghan I; Basu, Anirban; Ollendorf, Daniel A; Cohen, Joshua T.

Value Health ; 25(1): 59-68, 2022 01.

Article in English | MEDLINE | ID: mdl-35031100

7.

The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies.

Ma, Siyu; Olchanski, Natalia; Cohen, Joshua T; Ollendorf, Daniel A; Neumann, Peter J; Kim, David D.

Value Health ; 25(8): 1336-1343, 2022 08.

Article in English | MEDLINE | ID: mdl-35315331

8.

Dementia Diagnosis Disparities by Race and Ethnicity.

Lin, Pei-Jung; Daly, Allan T; Olchanski, Natalia; Cohen, Joshua T; Neumann, Peter J; Faul, Jessica D; Fillit, Howard M; Freund, Karen M.

Med Care ; 59(8): 679-686, 2021 08 01.

Article in English | MEDLINE | ID: mdl-34091580

9.

Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.S.

Leech, Ashley A; Neumann, Peter J; Cohen, Joshua T; Jagasia, Madan; Dusetzina, Stacie B.

Oncologist ; 25(7): e1117-e1119, 2020 07.

Article in English | MEDLINE | ID: mdl-32386072

10.

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs.

Chambers, James D; Silver, Madison C; Berklein, Flora C; Cohen, Joshua T; Neumann, Peter J.

J Gen Intern Med ; 35(9): 2629-2636, 2020 09.

Article in English | MEDLINE | ID: mdl-32291711

11.

Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China.

Ma, Siyu; Kim, David D; Cohen, Joshua T; Neumann, Peter J.

Value Health ; 23(11): 1405-1408, 2020 11.

Article in English | MEDLINE | ID: mdl-33127009

12.

Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?

Feng, Xue; Kim, David D; Cohen, Joshua T; Neumann, Peter J; Ollendorf, Daniel A.

Int J Technol Assess Health Care ; 36(2): 96-103, 2020 Apr.

Article in English | MEDLINE | ID: mdl-32340631

13.

Preparing the health-care system to pay for new Alzheimer's drugs.

Lin, Pei-Jung; Cohen, Joshua T; Neumann, Peter J.

Alzheimers Dement ; 16(11): 1568-1570, 2020 11.

Article in English | MEDLINE | ID: mdl-32808733

14.

Drug-Pricing Debate Redux - Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?

Neumann, Peter J; Cohen, Joshua T; Ollendorf, Daniel A.

N Engl J Med ; 385(21): 1923-1924, 2021 Nov 18.

Article in English | MEDLINE | ID: mdl-34767318

15.

Patient selection in palliative surgery: Defining value.

Cohen, Joshua T; Miner, Thomas J.

J Surg Oncol ; 120(1): 35-44, 2019 Jul.

Article in English | MEDLINE | ID: mdl-31124162

16.

Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments?

Cohen, Joshua T; Silver, Madison C; Ollendorf, Daniel A; Neumann, Peter J.

Value Health ; 22(12): 1396-1401, 2019 12.

Article in English | MEDLINE | ID: mdl-31806196

17.

Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports.

Snider, Julia Thornton; Sussell, Jesse; Tebeka, Mahlet Gizaw; Gonzalez, Alicia; Cohen, Joshua T; Neumann, Peter.

Value Health ; 22(3): 332-339, 2019 Mar.

Article in English | MEDLINE | ID: mdl-30832971

18.

Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.

Kumar, Vaibhav; Cohen, Joshua T; van Klaveren, David; Soeteman, Djøra I; Wong, John B; Neumann, Peter J; Kent, David M.

Ann Intern Med ; 168(3): 161-169, 2018 02 06.

Article in English | MEDLINE | ID: mdl-29297005

19.

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.

Parsons, Susan K; Kelly, Michael J; Cohen, Joshua T; Castellino, Sharon M; Henderson, Tara O; Kelly, Kara M; Keller, Frank G; Henzer, Tobi J; Kumar, Anita J; Johnson, Peter; Meyer, Ralph M; Radford, John; Raemaekers, John; Hodgson, David C; Evens, Andrew M.

Br J Haematol ; 182(2): 212-221, 2018 07.

Article in English | MEDLINE | ID: mdl-29707774

20.

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.

Leech, Ashley A; Kim, David D; Cohen, Joshua T; Neumann, Peter J.

Value Health ; 21(7): 759-761, 2018 07.

Article in English | MEDLINE | ID: mdl-30005746

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: